マイクロバイオームの世界市場レポート2025

マイクロバイオーム市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）15.0％で14億3,000万米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、オーダーメイド医療への要求の高まり、資金の増加、技術の進歩、慢性疾患の有病率の上昇に起因します。予測期間の主な動向には、人工知能の使用、戦略的提携と契約、収益向上とカテゴリーリーダーシップの確立、さまざまな疾患を治療するマイクロバイオーム治療薬を開発するためのパイプライン研究の増加、腫瘍マイクロバイオーム治療薬の開発への投資の検討、精密技術の生産性、効率性、精度の向上などがあります。

炎症性腸疾患（IBD）の有病率の増加は、マイクロバイオーム市場の成長を促進する重要な要因です。IBDは、消化管、特に胃腸（GI）管に影響を及ぼす慢性炎症性疾患群を包含します。IBDへの注目は、この疾患における腸マイクロバイオームの重要な役割を浮き彫りにし、その結果、マイクロバイオームを中心とした調査、診断、治療が急増し、市場の拡大に拍車をかけています。例えば、米国を拠点とする消化器専門医の医療団体である米国消化器病学会（AGA）は2022年9月、米国人の40％が不快な腸症状のために日常生活に支障をきたしていると報告しました。さらに、6,000万人から7,000万人のアメリカ人が、生活の質を著しく損なう消化器疾患に罹患しています。したがって、IBDの有病率の上昇は、マイクロバイオーム市場の成長を促進すると予想されます。

ヘルスケア支出の増加は、マイクロバイオーム市場の成長をさらに刺激すると予想されます。ヘルスケア支出とは、特定のヘルスケアシステムや経済において、特定の時間枠の中でヘルスケアサービス、商品、活動に割り当てられる総資金を指します。これらの支出はマイクロバイオーム市場を発展させる上で極めて重要です。マイクロバイオームの研究開発への投資が増加し、マイクロバイオームが人間の健康にとって重要であるという認識が高まるにつれ、マイクロバイオームをベースとした治療法や製品に対する需要が高まっています。例えば、2022年3月、米国連邦政府機関であるメディケア・メディケイド・サービスセンター（CMS）は、2021年から2030年にかけて国民医療費が年平均5.1％増加し、2030年には約6兆8,000億米ドルに達すると予測しました。そのため、医療費の増大がマイクロバイオーム市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界マイクロバイオームPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のマイクロバイオーム市場：成長率分析
• 世界のマイクロバイオーム市場の実績：規模と成長, 2019-2024
• 世界のマイクロバイオーム市場の予測：規模と成長, 2024-2029, 2034F
• 世界マイクロバイオーム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のマイクロバイオーム市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌
• 古細菌
• ウイルス
• その他のマイクロバイオーム
• 世界のマイクロバイオーム市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療薬
• 診断
• 世界のマイクロバイオーム市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲノミクス
• プロテオミクス
• メタボロミクス
• 世界のマイクロバイオーム市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 胃腸障害
• 代謝障害
• がん
• その他の病気
• 世界のマイクロバイオーム市場細菌の種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プロバイオティクス細菌
• 病原細菌
• 環境細菌
• さまざまな生態系における細菌群集
• 世界のマイクロバイオーム市場、古細菌のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メタン生成菌
• 好塩菌
• 好酸性菌
• その他の極限環境生物
• 世界のマイクロバイオーム市場、ウイルスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バクテリオファージ
• 真核生物ウイルス
• 環境ウイルス
• 世界のマイクロバイオーム市場、その他のマイクロバイオームのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 菌類
• 原生生物
• 蠕虫
• マイコバイオーム

第7章 地域別・国別分析

• 世界のマイクロバイオーム市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のマイクロバイオーム市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• マイクロバイオーム市場：競合情勢
• マイクロバイオーム市場：企業プロファイル
  • Seres Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • Enterome Bioscience Overview, Products and Services, Strategy and Financial Analysis
  • Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • Vedanta BioSciences Overview, Products and Services, Strategy and Financial Analysis
  • Second Genome Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Microbiotica
• Rebiotix, Inc
• Locus Biosciences
• Osel Inc.
• Xbiome Co., Ltd
• Microba Life Sciences
• Biome Australia
• Shoreline Biome
• Leucine Rich Bio Pvt Ltd
• BugSpeaks
• KINS Co., Ltd
• Yeda Research and Development Co. Ltd
• China National Pharmaceutical Group Corporation
• Atlas Biomed
• BiomX Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• マイクロバイオーム市場2029：新たな機会を提供する国
• マイクロバイオーム市場2029：新たな機会を提供するセグメント
• マイクロバイオーム市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A microbiome refers to a community of microbes inhabiting a specific habitat, comprising fungi, bacteria, and viruses. It encompasses all the genetic material of bacteria, fungi, protozoa, and viruses that reside on and within the human body. The bacteria within the microbiome play crucial roles in digestion, immune system regulation, defense against disease-causing bacteria, and the production of essential vitamins such as Vitamin K, necessary for blood clotting, and B vitamins such as B12, thiamine, and riboflavin.

The primary types of microbiomes include bacteria, archaea, viruses, and other microorganisms. Bacteria, single-celled microorganisms belonging to the domain Bacteria, are diverse and abundant life forms found in various environments. Products associated with microbiomes include therapeutics and diagnostics, and technologies such as genomics, proteomics, and metabolomics are employed in conditions such as inflammatory bowel disease, gastrointestinal disorders, metabolic disorders, cancers, and other diseases.

The microbiome market research report is one of a series of new reports from The Business Research Company that provides microbiome market statistics, including microbiome industry global market size, regional shares, competitors with a microbiome market share, detailed microbiome market segments, market trends, and opportunities, and any further data you may need to thrive in the microbiome industry. This microbiome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microbiome market size has grown exponentially in recent years. It will grow from $0.68 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to increased need for immunology, increasing collaborations, government initiatives, increased healthcare expenditure and growth in the number of healthcare facilities.

The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.43 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to rise in healthcare expenditure, rising requirement for customized medicine, increasing funding, technological advances and rising prevalence of chronic diseases. Major trends in the forecast period include use of artificial intelligence, strategic collaborations and agreements, boost revenues and establish category leadership, increasing the number of pipeline studies to develop microbiome therapeutics to treat different diseases, consider investing in the development of oncology microbiome therapeutics and to improve productivity, efficiency and accuracy of the precision technologies.

The growing prevalence of inflammatory bowel disease (IBD) is a significant factor propelling the growth of the microbiome market. IBD encompasses a group of chronic inflammatory disorders that impact the digestive tract, particularly the gastrointestinal (GI) tract. This focus on IBD has highlighted the crucial role of the gut microbiome in the disease, resulting in a surge of research, diagnostics, and therapies centered on the microbiome, which is fueling the market's expansion. For example, in September 2022, the American Gastroenterological Association (AGA), a U.S.-based medical association for gastroenterologists, reported that 40% of Americans have disrupted their daily activities due to uncomfortable bowel symptoms. Additionally, 60-70 million Americans are affected by gastrointestinal diseases that significantly impair their quality of life. Thus, the rising prevalence of IBD is expected to drive the growth of the microbiome market.

Increasing healthcare expenditure is anticipated to further stimulate the growth of the microbiome market. Healthcare expenditure refers to the total funds allocated for healthcare services, goods, and activities within a particular healthcare system or economy over a specified timeframe. These expenditures are crucial for advancing the microbiome market. With rising investments in microbiome research and development and growing awareness of the microbiome's importance for human health, there is an increasing demand for microbiome-based therapies and products. For instance, in March 2022, the Centers for Medicare and Medicaid Services (CMS), a U.S. federal agency, projected that national health spending would rise by an average of 5.1% annually between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Therefore, the escalation in healthcare expenditures is driving growth in the microbiome market.

Technological improvement is emerging as a significant trend in the microbiome market. Major companies in the microbiome sector are actively developing advanced technological solutions, such as Seed's introduction of the Probiotic and Prebiotic Daily Synbiotic for both females and males. Seed's Daily Synbiotic adopts a microbe-system strategy, providing strain-specific benefits beyond digestive health, including cardiac safety, dermatological health, immune control, reproductive health, gut barrier integrity, and oxidative stress.

Major companies in the microbiome market are prioritizing innovation, such as personalized health insights designed to empower individuals by providing tailored reports that highlight specific health issues. Personalized health insights entail customized, data-driven information and recommendations tailored to an individual's unique health profile. For instance, in September 2024, Redcliffe Labs, an India-based medical and diagnostic laboratory company, introduced Gut Microbiome and HealthEx tests aimed at improving preventive healthcare through personalized health insights. These two specialized health tests focus on promoting preventive healthcare. The gut microbiome test evaluates gut health and provides insights into immune function, metabolism, and mental well-being. Meanwhile, an advanced blood test analyzes DNA to identify potential health risks associated with lifestyle, diet, and genetics. Both tests offer personalized recommendations to help individuals manage their health effectively.

In December 2023, L'Oreal S.A., a France-based cosmetics company, acquired Lactobio for an undisclosed sum. This acquisition aims to enhance L'Oreal S.A.'s expertise in microbiome science, enriching its product offerings by integrating innovative probiotic-based solutions. Lactobio, a biotechnology research company based in Denmark, utilizes microbiome science to develop novel health interventions.

Major companies operating in the microbiome market include Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc, Locus Biosciences, Osel Inc., Xbiome Co., Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd, BugSpeaks, KINS Co., Ltd, Yeda Research and Development Co. Ltd, China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome

North America was the largest region in the microbiome market in 2024. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the microbiome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The microbiome market consists of sales of firmicutes, bacteroidetes, and actinobacteria. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microbiome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microbiome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microbiome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microbiome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
• 2) By Product: Therapeutics, Diagnostics
• 4) By Technology: Genomics, Proteomics, Metabolomics
• 3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
• Subsegments:
• 1) By Bacteria: Probiotic Bacteria; Pathogenic Bacteria; Environmental Bacteria; Bacterial Communities In Various Ecosystems
• 2) By Archaea: Methanogens; Halophiles; Acidophiles; Other Extremophiles
• 3) By Viruses: Bacteriophages; Eukaryotic Viruses; Environmental Viruses
• 4) By Other Microbiomes: Fungi; Protists; Helminths; Mycobiome
• Companies Mentioned: Seres Therapeutics; Enterome Bioscience; Ferring Pharmaceuticals; Vedanta BioSciences; Second Genome Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microbiome Market Characteristics

3. Microbiome Market Trends And Strategies

4. Microbiome Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Microbiome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microbiome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microbiome Market Growth Rate Analysis
• 5.4. Global Microbiome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microbiome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microbiome Total Addressable Market (TAM)

6. Microbiome Market Segmentation

• 6.1. Global Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacteria
• Archaea
• Viruses
• Other Microbiomes
• 6.2. Global Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Diagnostics
• 6.3. Global Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomics
• Proteomics
• Metabolomics
• 6.4. Global Microbiome Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Gastrointestinal Disorders
• Metabolic Disorders
• Cancers
• Other Diseases
• 6.5. Global Microbiome Market, Sub-Segmentation Of Bacteria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Probiotic Bacteria
• Pathogenic Bacteria
• Environmental Bacteria
• Bacterial Communities In Various Ecosystems
• 6.6. Global Microbiome Market, Sub-Segmentation Of Archaea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methanogens
• Halophiles
• Acidophiles
• Other Extremophiles
• 6.7. Global Microbiome Market, Sub-Segmentation Of Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacteriophages
• Eukaryotic Viruses
• Environmental Viruses
• 6.8. Global Microbiome Market, Sub-Segmentation Of Other Microbiomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fungi
• Protists
• Helminths
• Mycobiome

7. Microbiome Market Regional And Country Analysis

• 7.1. Global Microbiome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microbiome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microbiome Market

• 8.1. Asia-Pacific Microbiome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microbiome Market

• 9.1. China Microbiome Market Overview
• 9.2. China Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microbiome Market

• 10.1. India Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microbiome Market

• 11.1. Japan Microbiome Market Overview
• 11.2. Japan Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microbiome Market

• 12.1. Australia Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microbiome Market

• 13.1. Indonesia Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microbiome Market

• 14.1. South Korea Microbiome Market Overview
• 14.2. South Korea Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microbiome Market

• 15.1. Western Europe Microbiome Market Overview
• 15.2. Western Europe Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microbiome Market

• 16.1. UK Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microbiome Market

• 17.1. Germany Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microbiome Market

• 18.1. France Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microbiome Market

• 19.1. Italy Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microbiome Market

• 20.1. Spain Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microbiome Market

• 21.1. Eastern Europe Microbiome Market Overview
• 21.2. Eastern Europe Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microbiome Market

• 22.1. Russia Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microbiome Market

• 23.1. North America Microbiome Market Overview
• 23.2. North America Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microbiome Market

• 24.1. USA Microbiome Market Overview
• 24.2. USA Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microbiome Market

• 25.1. Canada Microbiome Market Overview
• 25.2. Canada Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microbiome Market

• 26.1. South America Microbiome Market Overview
• 26.2. South America Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microbiome Market

• 27.1. Brazil Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microbiome Market

• 28.1. Middle East Microbiome Market Overview
• 28.2. Middle East Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microbiome Market

• 29.1. Africa Microbiome Market Overview
• 29.2. Africa Microbiome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microbiome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microbiome Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microbiome Market Competitive Landscape And Company Profiles

• 30.1. Microbiome Market Competitive Landscape
• 30.2. Microbiome Market Company Profiles
  • 30.2.1. Seres Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Enterome Bioscience Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ferring Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Vedanta BioSciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Second Genome Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Microbiome Market Other Major And Innovative Companies

• 31.1. Microbiotica
• 31.2. Rebiotix, Inc
• 31.3. Locus Biosciences
• 31.4. Osel Inc.
• 31.5. Xbiome Co., Ltd
• 31.6. Microba Life Sciences
• 31.7. Biome Australia
• 31.8. Shoreline Biome
• 31.9. Leucine Rich Bio Pvt Ltd
• 31.10. BugSpeaks
• 31.11. KINS Co., Ltd
• 31.12. Yeda Research and Development Co. Ltd
• 31.13. China National Pharmaceutical Group Corporation
• 31.14. Atlas Biomed
• 31.15. BiomX Ltd

32. Global Microbiome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microbiome Market

34. Recent Developments In The Microbiome Market

35. Microbiome Market High Potential Countries, Segments and Strategies

• 35.1 Microbiome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microbiome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microbiome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer